Phacoemulsification System Market Report 2026

Phacoemulsification System Market Overview

• Phacoemulsification System market size has reached to $1.51 billion in 2025 • Expected to grow to $2.16 billion in 2030 at a compound annual growth rate (CAGR) of 7.3% • Growth Driver: Surge In Minimally Invasive Ophthalmic Procedures Fueling The Growth Of The Market Due To Faster Recovery Demand • Market Trend: Use Of Advanced Fluidics And Intelligent Technologies In Phacoemulsification Systems To Improve Surgical Precision • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Phacoemulsification System Market?

Phacoemulsification systems refer to advanced medical devices that use ultrasonic energy to emulsify and remove the eye’s natural lens during cataract surgery, allowing for the implantation of an artificial intraocular lens (IOL) to restore clear vision. They are designed to provide precise control of fluidics, pressure, and energy delivery, ensuring safety, efficiency, and optimal surgical outcomes. The main product type of phacoemulsification systems are standalone phacoemulsification systems and portable phacoemulsification systems. Standalone phacoemulsification systems refer to fully integrated, stationary surgical units designed exclusively for performing phacoemulsification procedures in ophthalmology. These systems use different technologies, including ultrasound, femtosecond laser, and other technologies, to support diverse ophthalmic procedures. The key disease indications addressed include cataract, presbyopia, glaucoma, and other disease indications. The primary applications involved are cataract surgery, refractive surgery, and other applications. These systems are used across various end-users such as hospitals, ophthalmic clinics, ambulatory surgical centers, and other end-users.

What Is The Phacoemulsification System Market Growth Forecast?

The phacoemulsification system market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growth in outpatient eye surgeries, technological innovation in ultrasound systems, rising demand for premium IOLs, expansion in emerging markets, increasing vision care awareness. Major trends in the forecast period include advanced fluidics control systems, minimally invasive cataract surgery adoption, high precision ultrasonic energy delivery, faster surgical procedure times, improved patient safety outcomes.

Global Phacoemulsification System Market Segmentation

1) By Product Type: Standalone Phacoemulsification Systems, Portable Phacoemulsification Systems 2) By Application: Cataract Surgery, Refractive Lens Exchange (RLE), Secondary Lens Removal Procedures 3) By End-User: Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Standalone Phacoemulsification Systems: Ultrasonic Handpiece Units, Control Console Units, Fluid Management Units, Illumination Module Units 2) By Portable Phacoemulsification Systems: Battery Powered Units, Compact Console Units, Handheld Operation Units, Mobile Surgical Kits

What Is The Driver Of The Phacoemulsification System Market?

The increasing adoption of minimally invasive ophthalmic procedures is expected to propel the growth of the phacoemulsification system market going forward. Minimally invasive ophthalmic procedures refer to advanced eye care techniques that use small incisions, micro-instruments, or laser-based approaches to diagnose or treat eye conditions with minimal tissue disruption. The rise in minimally invasive ophthalmic procedures is due to the growing preference for faster recovery, as these techniques reduce surgical trauma and allow patients to resume daily activities much sooner. Phacoemulsification system helps minimally invasive ophthalmic procedures by using ultrasonic energy to break and remove the cataract through a tiny incision, enabling faster healing, reduced tissue damage, and improved surgical precision. For instance, in May 2024, according to Gov.UK, a UK-based government agency, there were 516,073 hospital admissions in England for cataract surgery among individuals aged 65 and above, representing a rate of 4,679 per 100,000 population in 2023. Therefore, increasing adoption of minimally invasive ophthalmic procedures is driving the growth of the phacoemulsification system industry.

Key Players In The Global Phacoemulsification System Market

Major companies operating in the phacoemulsification system market are Alcon, Johnson & Johnson, Bausch + Lomb, NIDEK, Oertli Instrumente, Optikon, Geuder, Appasamy Associates, Biotech Visioncare, Meda, SIFI, Ziemer Ophthalmic Systems, Topcon, Carl Zeiss Meditec, Huvitz, Rumex International, DORC International, MicroSurgical Technology, LIGHTMED, Aurolab, MTP Medical Technical Products

Global Phacoemulsification System Market Trends and Insights

Major companies operating in the phacoemulsification system market are focusing on integration of femtosecond laser technology such as the novel fluidics concept to maintain stable intraocular pressure (IOP), to enhance chamber stability, and ensure consistent fluid control throughout all phases of cataract surgery, thereby improving surgical precision and patient safety. Novel fluidics concept refers to an advanced fluid management technology in phacoemulsification systems that precisely regulates the balance between irrigation and aspiration during eye surgery. For instance, in September 2025, Beaver-Visitec International, Inc. (BVI), a US-based ophthalmic medical device company, unveiled Virtuoso a novel dual-function phaco-vitrectomy surgical platform designed for both cataract and vitreoretinal procedures. The system features a novel fluidics concept that maintains target intraocular pressure (IOP) throughout all surgical steps, a hybrid flow and pressure pump design for superior chamber stability, and Load Sensing Phaco technology that automatically adjusts ultrasound energy based on lens resistance to enhance precision and surgical efficiency.

What Are Latest Mergers And Acquisitions In The Phacoemulsification System Market?

In January 2024, Rayner Group, a UK-based ophthalmic technology company, acquired This AG for an undisclosed amount. Through this acquisition, Rayner aims to strengthen its cataract-surgery portfolio by integrating advanced phaco-emulsification capabilities and expanding its presence in global surgical ophthalmology. This AG is a Switzerland-based ophthalmic technology company that develops phacoemulsificatiom systems.

Regional Outlook

North America was the largest region in the phacoemulsification system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Phacoemulsification System Market?

The phacoemulsification systems market consists of sales of surgical equipment, consoles, handpieces, tubing sets, cassettes, and irrigation or aspiration components. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.